FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912532602> ?p ?o ?g. }

• W2912532602 endingPage "586" @default.
• W2912532602 startingPage "586" @default.
• W2912532602 abstract "Cancer immune therapy has recently shown tremendous promise to combat many different cancers. The microtubule is a well-defined and very effective cancer therapeutic target. Interestingly, several lines of evidence now suggest that microtubules are intimately connected to the body’s immune responses. This raises the possibility that the combination of microtubule inhibitors and immune therapy can be a highly effective option for cancer treatments. However, our understanding on this potentially important aspect is still very limited, due in part to the multifaceted nature of microtubule functions. Microtubules are not only involved in maintaining cell morphology, but also a variety of cellular processes, including the movement of secretory vesicles and organelles, intracellular macromolecular assembly, signaling pathways, and cell division. Microtubule inhibitors may be subdivided into two classes: Anti-depolymerization agents such as the taxane family, and anti-polymerization agents such as colchicine and vinka alkaloids. These two different classes may have different effects on immune cell subtypes. Anti-depolymerization agents can not only induce NK cells, but also appear to inhibit T regulatory (Treg) cells. However, different inhibitors may have different functions even among the same class. For example, the doxetaxel anti-depolymerization agent up-regulates cytotoxic T cells, while paclitaxel down-regulates them. Certain anti-polymerization agents such as colchicine appear to down-regulate most immune cell types, while inducing dendritic cell maturation and increasing M1 macrophage population. In contrast, the vinblastine anti-polymerization agent activates many of these cell types, albeit down-regulating Treg cells. In this review, we focus on the various effects of tubulin inhibitors on the activities of the body’s immune system, in the hope of paving the way to develop an effective cancer therapy by combining tubulin-targeting anticancer agents and immune therapy." @default.
• W2912532602 created "2019-02-21" @default.
• W2912532602 creator A5044748206 @default.
• W2912532602 creator A5050677879 @default.
• W2912532602 creator A5081855378 @default.
• W2912532602 date "2019-01-30" @default.
• W2912532602 modified "2023-10-18" @default.
• W2912532602 title "The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy" @default.
• W2912532602 cites W110542923 @default.
• W2912532602 cites W1153335416 @default.
• W2912532602 cites W137722765 @default.
• W2912532602 cites W146153732 @default.
• W2912532602 cites W1518270672 @default.
• W2912532602 cites W1771257283 @default.
• W2912532602 cites W1779409385 @default.
• W2912532602 cites W1818000388 @default.
• W2912532602 cites W1900821731 @default.
• W2912532602 cites W1913219728 @default.
• W2912532602 cites W1953823245 @default.
• W2912532602 cites W1963569255 @default.
• W2912532602 cites W1963878289 @default.
• W2912532602 cites W1968785826 @default.
• W2912532602 cites W1974361740 @default.
• W2912532602 cites W1982396007 @default.
• W2912532602 cites W1984378291 @default.
• W2912532602 cites W1990613023 @default.
• W2912532602 cites W1998074965 @default.
• W2912532602 cites W2004302235 @default.
• W2912532602 cites W2007917102 @default.
• W2912532602 cites W2008748524 @default.
• W2912532602 cites W2016532947 @default.
• W2912532602 cites W2027065592 @default.
• W2912532602 cites W2029726426 @default.
• W2912532602 cites W2040372792 @default.
• W2912532602 cites W2043478531 @default.
• W2912532602 cites W2044835625 @default.
• W2912532602 cites W2051748894 @default.
• W2912532602 cites W2061990495 @default.
• W2912532602 cites W2068331519 @default.
• W2912532602 cites W2070611680 @default.
• W2912532602 cites W2073503439 @default.
• W2912532602 cites W2075273760 @default.
• W2912532602 cites W2080820250 @default.
• W2912532602 cites W2082962820 @default.
• W2912532602 cites W2086000565 @default.
• W2912532602 cites W2097074641 @default.
• W2912532602 cites W2097581069 @default.
• W2912532602 cites W2100820895 @default.
• W2912532602 cites W2102214961 @default.
• W2912532602 cites W2108221027 @default.
• W2912532602 cites W2115653675 @default.
• W2912532602 cites W2117918558 @default.
• W2912532602 cites W2124145182 @default.
• W2912532602 cites W2124910438 @default.
• W2912532602 cites W2140980839 @default.
• W2912532602 cites W2150922701 @default.
• W2912532602 cites W2152242415 @default.
• W2912532602 cites W2153385228 @default.
• W2912532602 cites W2154747925 @default.
• W2912532602 cites W2166332777 @default.
• W2912532602 cites W2172268423 @default.
• W2912532602 cites W2278665679 @default.
• W2912532602 cites W2329688336 @default.
• W2912532602 cites W2411015969 @default.
• W2912532602 cites W2493796394 @default.
• W2912532602 cites W2543756589 @default.
• W2912532602 cites W2556393965 @default.
• W2912532602 cites W2758278214 @default.
• W2912532602 cites W2760780444 @default.
• W2912532602 cites W2767551096 @default.
• W2912532602 cites W2774949562 @default.
• W2912532602 cites W2778102091 @default.
• W2912532602 cites W2782035861 @default.
• W2912532602 cites W2783237763 @default.
• W2912532602 cites W2895125473 @default.
• W2912532602 cites W29902740 @default.
• W2912532602 cites W4244404389 @default.
• W2912532602 cites W4299333187 @default.
• W2912532602 cites W48985345 @default.
• W2912532602 doi "https://doi.org/10.3390/ijms20030586" @default.
• W2912532602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6387102" @default.
• W2912532602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30704031" @default.
• W2912532602 hasPublicationYear "2019" @default.
• W2912532602 type Work @default.
• W2912532602 sameAs 2912532602 @default.
• W2912532602 citedByCount "32" @default.
• W2912532602 countsByYear W29125326022019 @default.
• W2912532602 countsByYear W29125326022020 @default.
• W2912532602 countsByYear W29125326022021 @default.
• W2912532602 countsByYear W29125326022022 @default.
• W2912532602 countsByYear W29125326022023 @default.
• W2912532602 crossrefType "journal-article" @default.
• W2912532602 hasAuthorship W2912532602A5044748206 @default.
• W2912532602 hasAuthorship W2912532602A5050677879 @default.
• W2912532602 hasAuthorship W2912532602A5081855378 @default.
• W2912532602 hasBestOaLocation W29125326021 @default.
• W2912532602 hasConcept C121608353 @default.
• W2912532602 hasConcept C203014093 @default.

• next